ALMIRALL, S.A. «...1112131415...» Page 14 out of 18 16/03/2021 08:30 ALMIRALL, S.A. On corporate transactions Almirall has decided not to exercise its option right to acquire Bioniz Therapeutics Inc. Register number: 7983 22/02/2021 06:32 ALMIRALL, S.A. Announcement of general shareholders’ meeting Convocatoria de la Junta General Ordinaria de Accionistas de la Sociedad Register number: 7181 22/02/2021 06:24 ALMIRALL, S.A. Annual report on directors´ remunerations La Sociedad remite el Informe Anual sobre remuneraciones de los consejeros del Ejercicio 2020 Register number: 7180 22/02/2021 06:22 ALMIRALL, S.A. Annual corporate governance report La sociedad remite el Informe Anual de Gobierno Corporativo del ejercicio 2020 Register number: 7179 22/02/2021 06:18 ALMIRALL, S.A. Other relevant information A webcast with analysts and institutional investors FY 2020 Register number: 7178 22/02/2021 06:03 ALMIRALL, S.A. Half-yearly financial reports and audit reports/limited audit review La sociedad remite información financiera del segundo semestre de 2020 Register number: 7177 17/02/2021 07:54 ALMIRALL, S.A. On corporate transactions Almirall and MC2 Therapeutics enter a License, Collaboration and Commercialization Agreement for European Rights to Wynzora® Cream for treatment of Plaque Psoriasis Register number: 7128 14/01/2021 17:31 ALMIRALL, S.A. Liquidity and counterparty agreements Operaciones del contrato de liquidez durante el cuarto trimestre de 2020 Register number: 6650 15/12/2020 12:44 ALMIRALL, S.A. Board of Directors Regulations La sociedad remite el reglamento del Consejo de Administración Register number: 6202 15/12/2020 08:47 ALMIRALL, S.A. On business and financial situation Almirall announces FDA approval of Klisyri® (tirbanibulin), a new topical treatment for actinic keratosis Register number: 6197 Page 14 out of 18 «...1112131415...»
